✦ LIBER ✦

Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions

✍ Scribed by Matthias Mehling; Ludwig Kappos; Tobias Derfuss

Book ID: 107545861
Publisher: Springer
Year: 2011
Tongue: English
Weight: 125 KB
Volume: 11
Category: Article
ISSN: 1528-4042
DOI: 10.1007/s11910-011-0216-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fingolimod in multiple sclerosis: Mechan

Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy

✍ Jens Ingwersen; Orhan Aktas; Patrick Kuery; Bernd Kieseier; Alexey Boyko; Hans-P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Mechanism of Action of Oral Fingolimod (

Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

✍ Chun, Jerold; Hartung, Hans-Peter 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 1001 KB

Pregnancy outcomes in the clinical devel

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

✍ Karlsson, G.; Francis, G.; Koren, G.; Heining, P.; Zhang, X.; Cohen, J. A.; Kapp 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 394 KB

Immunological Mechanism of Action and Cl

Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis

✍ Du Pasquier, Renaud A.; Pinschewer, Daniel D.; Merkler, Doron 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 462 KB

Clinical outcomes and documentation of p

Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis

✍ John N. Whitaker; Galen W. Mitchell; Gary R. Cutter 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Discovery of fingolimod, the sphingosine

Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis

✍ Chiba, Kenji; Adachi, Kunitomo 📂 Article 📅 2012 🏛 Future Science 🌐 English ⚖ 956 KB